Alector (ALEC) Cash from Operations Growth (1y) (2019 - 2026)
Alector (ALEC) Cash from Operations Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | - |
| 10 | Alector | 170.31 Mn | -36.21 Mn | - | 18.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.05% |
| Dec 31, 2025 | 24.24% |
| Sep 30, 2025 | 35.92% |
| Jun 30, 2025 | 21.90% |
| Mar 31, 2025 | 0.92% |
| Dec 31, 2024 | -19.44% |
| Sep 30, 2024 | -9.01% |
| Jun 30, 2024 | -46.03% |
| Mar 31, 2024 | -26.36% |
| Dec 31, 2023 | 5.84% |
| Sep 30, 2023 | 5.12% |
| Jun 30, 2023 | 25.13% |
| Mar 31, 2023 | -135.94% |
| Dec 31, 2022 | 0.69% |
| Sep 30, 2022 | -111.02% |
| Jun 30, 2022 | -28.96% |
| Mar 31, 2022 | 356.37% |
| Dec 31, 2021 | -3.37% |
| Sep 30, 2021 | 1,190.25% |
| Jun 30, 2021 | 3.05% |